Skip to main content
Premium Trial:

Request an Annual Quote

Icoria Unit Paradigm Signs Three Gene-Expression Contracts Worth $1.1M

NEW YORK, Sept. 8 (GenomeWeb News) - Icoria business unit Paradigm Array Labs has signed three service contracts worth an estimated $1.1 million with DukeUniversity, the US Environmental Protection Agency, and an undisclosed biotechnology company, the firm said today.


"We have already exceeded 2004 revenues and are aggressively pursuing new business opportunities, including projects related to clinical trials," Faye O'Brien, senior business director of Icoria, said in the statement. Paradigm is the gene expression-profiling service unit of Research Triangle Park, NC-based Icoria.


The DukeUniversitycontract is focused on the study of environmental toxicants and their affect on humans and the environment, and involves four years of research on "multiple organisms" for the university's SuperfundBasicResearchCenter, according to Paradigm.


The two-year EPA contract involves a custom microarray for zebrafish designed by Icoria and produced by Agilent, Paradigm said. That contract is also related to the study of environmental toxicants, the company said.


Of its third contract with the unnamed biotech company, Paradigm said only that its work is "underway and is expected to be completed by the third quarter of 2006."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.